Everything is ready in Brussels to host EFIB 2013

Brussels, Midi Train Station
Brussels, Midi Train Station

Everything is ready in Brussels to host EFIB, the European Forum for Industrial Biotechnology and Bio-based economy organized by EuropaBio, the European Association for Bioindustries, and Smithers Rapra which will take place from September 30 to October 2, during the European Biotech Week (from September 30 to October 4), when events across Europe will celebrate biotechnology, an innovative and vibrant sector launched by the 1953 discovery of the DNA molecule, sixty years ago.

The programme of EFIB features parallel tracks enabling delegates to build their agenda choosing from presentations on a range of recent developments.  Delegates pick from the ever-popular innovation track, showcasing the brightest and best new innovations in industrial biotechnology from 2012-2013, or shorter in-depth focus tracks on sustainable and competitive feedstocks, international policy from the Americas and Asia, financing the bioeconomy.

Highlights of the sessions include Venture Capitalist, Jos Peeters, presenting an overview of financing for the biobased economy, perspectives on sustainable EU feedstock by Pekka Pesonen, Secretary General at Copa Cogeca, and insight into the current US biotechnology policy situation from Erick Lutt at BIO.  Also this year, the innovation track showcases technological breakthroughs, new processes for innovative biobased products and innovative tools in the biobased economy from companies including Solvay, Direvo and BioAmber.

“We are delighted to host EFIB, in Brussels (Square Meeting Center) again this year, both during the first ever EU Biotech week and on the occasion of its transformation from conference to congress. EFIB has always been a crucible for forming new policy ideas and innovative business connections for biobased industries.  This year will be no exception and we look forward to showcasing the brightest and the best developments of 2013 to a record number of participants”, says Nathalie Moll, Secretary General, EuropaBio.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.